Minocycline Extended-Release Tablets and Ranibizumab Intraocular
Determining the interaction of Minocycline Extended-Release Tablets and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: minocycline
Brand name: Dynacin, Minocin, Minocin PAC, Minolira, Solodyn, Ximino, Vectrin, Myrac
Synonyms: Minocycline, Minocycline (Systemic)
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Minocycline Extended-Release Tablets-Ranibizumab ophthalmic
- Minocycline Extended-Release Tablets-Ranitidine
- Minocycline Extended-Release Tablets-Ranitidine Capsule
- Minocycline Extended-Release Tablets-Ranitidine Hydrochloride
- Minocycline Extended-Release Tablets-Ranitidine Injection
- Minocycline Extended-Release Tablets-Ranitidine Suspension
- Ranibizumab Intraocular-Minocycline Hydrochloride
- Ranibizumab Intraocular-Minocycline Hydrochloride eent
- Ranibizumab Intraocular-Minocycline Hydrochloride Periodontal Microspheres
- Ranibizumab Intraocular-Minocycline Injection
- Ranibizumab Intraocular-Minocycline Intravenous
- Ranibizumab Intraocular-Minocycline mucous membrane powder